MUSTANG BIO, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
MUSTANG BIO, INC. (MBIO) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $77.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-03-28
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $77.00K.
- 2024-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $99.00K.
- 2024-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.83M.
- 2024-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $514.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2024-12-31 | $77.00K 10-K · filed 2025-03-28 |
| 2024-09-30 | $99.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.83M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $514.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $548.00K 10-K · filed 2024-03-11 |
| 2023-09-30 | $604.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $663.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.35M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.44M 10-K · filed 2023-03-30 |
| 2022-09-30 | $1.57M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $481.00K 10-K · filed 2022-03-23 |
| 2021-03-31 | $613.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $662.00K 10-K · filed 2021-03-24 |
| 2020-09-30 | $713.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $766.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $820.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $866.00K 10-K · filed 2020-03-16 |
| 2019-09-30 | $914.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $994.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.07M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |